Vitrolife AB (VITR)

Currency in SEK
108.80
+6.10(+5.94%)
Closed·
VITR is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
103.10109.40
52 wk Range
84.00152.50
Key Statistics
Prev. Close
108.8
Open
104
Day's Range
103.1-109.4
52 wk Range
84-152.5
Volume
258.55K
Average Volume (3m)
218.63K
1-Year Change
-27.9947%
Book Value / Share
59,95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VITR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
132.00
Upside
+21.32%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Vitrolife AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 132.00
(+21.32% Upside)

Vitrolife AB Earnings Call Summary for Q3/2026

  • Vitrolife Q3 sales rose 6% organically to SEK 884M with EBITDA of SEK 279M, driven by strong Technologies demand and restructuring gains.
  • Earnings per share increased to SEK 0.94 from SEK 0.75 year-over-year, with analysts expecting continued profitability and net income growth.
  • Stock traded flat at $97.7, down 0.1%, but faces significant headwinds with a 28% year-to-date decline despite improved operational performance.
  • InvestingPro analysis indicates shares are currently undervalued based on Fair Value assessment following the company's restructuring efforts.
Last Updated: 2026/10/22, 10:58
Read Full Transcript

Earnings

Latest Release
Oct 22, 2026
EPS / Forecast
0,92 / 1,01
Revenue / Forecast
884M / 856,58M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -36,70
Dividend Yield
1.01%
Industry Median 1.58%
Annualised payout
1.10
Paid annually
5-Years Growth
+6.58%
Growth Streak

VITR Income Statement

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Employees
1088
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
19,65M14,81%2,14B
Other Institutional Investors
89,72M67,60%9,76B
Public Companies & Retail Investors
23,35M17,59%2,54B
Total
132,73M100,00%14,44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
William Demant Invest A/S30,25%40 154 5564 368 816
Bure Equity AB (publ)16,21%21 510 2572 340 316

FAQ

What Is the Vitrolife (VITR) Stock Price Today?

The Vitrolife stock price today is 108,80 SEK.

What Stock Exchange Does Vitrolife Trade On?

Vitrolife is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Vitrolife?

The stock symbol for Vitrolife is "VITR."

Does Vitrolife Pay Dividends? What’s The Current Dividend Yield?

The Vitrolife dividend yield is 1,0%%.

What Is the Vitrolife Market Cap?

As of today, Vitrolife market cap is 14,44B SEK.

What Is Vitrolife's Earnings Per Share (TTM)?

The Vitrolife EPS (TTM) is -36,70.

When Is the Next Vitrolife Earnings Date?

Vitrolife will release its next earnings report on Jan 28, 2027.

From a Technical Analysis Perspective, Is VITR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vitrolife Stock Split?

Vitrolife has split 1 times.

How Many Employees Does Vitrolife Have?

Vitrolife has 1088 employees.

What is the current trading status of Vitrolife (VITR)?

As of Oct 26, 2026, Vitrolife (VITR) is trading at a price of 108,80 SEK, with a previous close of 108,80 SEK. The stock has fluctuated within a day range of 103,10 SEK to 109,40 SEK, while its 52-week range spans from 84,00 SEK to 152,50 SEK.

What Is Vitrolife (VITR) Price Target According to Analysts?

The average 12-month price target for Vitrolife is 132,00 SEK, with a high estimate of 155 SEK and a low estimate of 100 SEK. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +21,32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.